Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
Therefore, our results indicate that USP4 has tumor suppressor roles in HNSCC and suggest USP4 as a potential therapeutic target for HNSCC.
|
23313255 |
2013 |
Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
Cells with stable USP4 reduction exhibited slower tumor growth rate and smaller tumor size than the control group cells in a xenograft mouse model.
|
30881035 |
2019 |
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
In a heterotropic patient-derived HCC xenograft model, USP4 was also overexpressed in G1 and G2 tumors when miR-148a was dysregulated, reflecting the closer link between miR-148a and USP4 for a shift in the expansion phase of tumorgraft.
|
24798342 |
2014 |
Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
We detected repression of a set of cellular growth-related genes by the TRPS1-USP4-HDAC2 axis indicating it is essential in tumor growth.
|
30071870 |
2018 |
Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
As a whole, our findings sugggest that USP4 acts as a tumor suppressor in breast cancer and that it may be an effective target for the treatment of breast cancer.
|
27430936 |
2016 |
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Moreover, in the subgroup of clinical stages 1 and 2 with tumor diameter ⩽ 5 cm, high USP4 expression prolonged the survival time of esophageal cancer patients more significantly (75.5% VS 5.9%, P= 0.000).
|
28946564 |
2017 |
Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
Moreover, Kaplan-Meier survival analysis showed a poor overall survival rate in patients with USP4-overexpressing tumors.
|
29396555 |
2018 |
Malignant Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
Taken together, the present study provides a novel insight into the regulation of the NF-κB signalling pathway and uncovers a previously unknown function of USP4 in cancer.
|
22029577 |
2012 |
Malignant Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
In this study, we aimed to explore the expression profile of USP4 in lung adenocarcinoma (LUAD) using large patient cohorts in the Cancer Genome Atlas and the International Cancer Genome Consortium and to investigate its prognostic value and the possible mechanisms of its dysregulation.
|
29667299 |
2018 |
Malignant Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
However, the mechanisms and regulatory roles of USP4 in cancer, including colorectal cancer, remain largely elusive.
|
26669864 |
2016 |
Malignant Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Ubiquitin-specific protease 4 (USP4) has recently been found to be elevated in various types of cancer through regulating P53 activity.
|
30655854 |
2019 |
Primary malignant neoplasm
|
0.040 |
AlteredExpression
|
group |
BEFREE |
In this study, we aimed to explore the expression profile of USP4 in lung adenocarcinoma (LUAD) using large patient cohorts in the Cancer Genome Atlas and the International Cancer Genome Consortium and to investigate its prognostic value and the possible mechanisms of its dysregulation.
|
29667299 |
2018 |
Primary malignant neoplasm
|
0.040 |
Biomarker
|
group |
BEFREE |
However, the mechanisms and regulatory roles of USP4 in cancer, including colorectal cancer, remain largely elusive.
|
26669864 |
2016 |
Primary malignant neoplasm
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Ubiquitin-specific protease 4 (USP4) has recently been found to be elevated in various types of cancer through regulating P53 activity.
|
30655854 |
2019 |
Primary malignant neoplasm
|
0.040 |
Biomarker
|
group |
BEFREE |
Taken together, the present study provides a novel insight into the regulation of the NF-κB signalling pathway and uncovers a previously unknown function of USP4 in cancer.
|
22029577 |
2012 |
Autoimmune Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Thus, USP4 could be a novel therapeutic target for the treatment of Th17-modulated autoimmune diseases.
|
25821221 |
2015 |
Carcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
Among genes that were most significantly upregulated in carcinomas were 2 ubiquitin-related genes (USP4 and UFD1L) and several insulinlike growth factor-related genes (IGF2, IGF2R, IGFBP3 and IGFBP6).
|
16360395 |
2005 |
Enterovirus Infections
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In this study, we found that enterovirus 71 (EV71) infection attenuated the expression of Ubiquitin-specific protease 4 (USP4) in vitro and in vivo, while overexpression of USP4 significantly suppressed EV71 replication.
|
30194441 |
2018 |
Esophageal Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Taken together, our study uncovered a previously unknown function of USP4 in esophageal cancer and more investigations would be carried out to further study its regulation gene network and molecular biological mechanism in esophageal cancer.
|
28946564 |
2017 |
Hepatitis
|
0.010 |
Biomarker
|
group |
BEFREE |
USP4 knockout mice exhibited exacerbated hepatic I/R injury, as evidenced by enhanced liver inflammation via the nuclear factor κB (NF-κB) signalling pathway and increased hepatocyte apoptosis.
|
30622220 |
2019 |
Metabolic Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Conclusion: Collectively, the present study provides evidence that USP4 functions as a pivotal suppressor in NAFLD and related metabolic disorders.(Hepatology 2018; 00:000-000).
|
29573006 |
2018 |
Secondary Neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Altogether, our results demonstrate that the up-regulated USP4 plays an oncogenic role in melanoma by simultaneously suppressing stress-induced cell apoptosis and facilitating tumour metastasis.
|
29542252 |
2018 |
Intelligence
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence.
|
29942086 |
2018 |
mathematical ability
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.
|
30038396 |
2018 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |